Laboratory Corp Amer Hldgs (LH) Market Value Rose While Healthcor Management LP Has Cut by $75.09 Million Its Holding

May 18, 2018 - By Winifred Garcia

Laboratory Corporation of America Holdings (NYSE:LH) LogoInvestors sentiment increased to 1.2 in Q4 2017. Its up 0.30, from 0.9 in 2017Q3. It improved, as 36 investors sold LH shares while 209 reduced holdings. 73 funds opened positions while 220 raised stakes. 91.47 million shares or 0.35% less from 91.79 million shares in 2017Q3 were reported. Evermay Wealth Management Lc invested in 0.33% or 5,676 shares. Williams Jones Assoc Lc stated it has 4,483 shares. Westpac Bk Corporation holds 0.02% or 5,861 shares. Hm Payson And owns 2,786 shares for 0.02% of their portfolio. The New York-based Fny Managed Accounts Limited has invested 0.22% in Laboratory Corporation of America Holdings (NYSE:LH). Hancock Hldgs Company owns 91,230 shares. Moreover, Andra Ap has 0.31% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 84,741 shares. Shine Investment Advisory Serv reported 554 shares or 0.04% of all its holdings. Bartlett And Ltd Liability invested in 0.88% or 139,102 shares. Ancora Advsrs Limited Liability holds 0.03% or 3,545 shares in its portfolio. Metropolitan Life Insurance New York has invested 0.03% in Laboratory Corporation of America Holdings (NYSE:LH). First Manhattan holds 26,752 shares. Employees Retirement Association Of Colorado has invested 0.02% in Laboratory Corporation of America Holdings (NYSE:LH). 27,170 are held by Cornercap Counsel Inc. Ssi Management holds 1,274 shares or 0.02% of its portfolio.

Since February 7, 2018, it had 0 insider purchases, and 5 insider sales for $18.70 million activity. ANDERSON KERRII B sold $548,124 worth of stock. The insider EISENBERG GLENN A sold $1.41 million. Another trade for 1,263 shares valued at $213,813 was sold by Schechter Adam H.

Arthur B Cohen decreased its stake in Laboratory Corp Amer Hldgs (LH) by 30.04% based on its latest 2017Q4 regulatory filing with the SEC. Healthcor Management Lp sold 472,290 shares as the company’s stock rose 1.25% while stock markets declined. The hedge fund run by Arthur B Cohen held 1.10M shares of the medical specialities company at the end of 2017Q4, valued at $175.46 million, down from 1.57 million at the end of the previous reported quarter. Healthcor Management Lp who had been investing in Laboratory Corp Amer Hldgs for a number of months, seems to be less bullish one the $18.07B market cap company. The stock increased 0.18% or $0.32 during the last trading session, reaching $176.62. About 33,694 shares traded. Laboratory Corporation of America Holdings (NYSE:LH) has risen 14.17% since May 18, 2017 and is uptrending. It has outperformed by 2.62% the S&P500.

Healthcor Management Lp, which manages about $3.20B and $3.07 billion US Long portfolio, upped its stake in Zoetis Inc (NYSE:ZTS) by 246,460 shares to 645,100 shares, valued at $46.47M in 2017Q4, according to the filing. It also increased its holding in Merck & Co Inc (NYSE:MRK) by 3.21 million shares in the quarter, for a total of 3.90 million shares, and has risen its stake in Zimmer Biomet Hldgs Inc (ZMH).

Analysts await Laboratory Corporation of America Holdings (NYSE:LH) to report earnings on July, 25. They expect $2.91 EPS, up 17.81 % or $0.44 from last year’s $2.47 per share. LH’s profit will be $297.69M for 15.17 P/E if the $2.91 EPS becomes a reality. After $2.78 actual EPS reported by Laboratory Corporation of America Holdings for the previous quarter, Wall Street now forecasts 4.68 % EPS growth.

More important recent Laboratory Corporation of America Holdings (NYSE:LH) news were published by: Streetinsider.com which released: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” on May 15, 2018, also Seekingalpha.com published article titled: “Laboratory of America Holdings (LH) Q1 2018 Results – Earnings Call Transcript”, Globenewswire.com published: “New Research Coverage Highlights Internap, Dime Community Bancshares, Cohu, Laboratory Corporation of America …” on May 18, 2018. More interesting news about Laboratory Corporation of America Holdings (NYSE:LH) was released by: Benzinga.com and their article: “Lab Stocks: Baird Favors Laboratory Corp., Says Quest Diagnostics Is The Simple Choice” with publication date: May 01, 2018.

Laboratory Corporation of America Holdings (NYSE:LH) Ratings Coverage

Among 14 analysts covering Laboratory Corp (NYSE:LH), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Laboratory Corp had 22 analyst reports since November 24, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, February 6 by Piper Jaffray. The stock of Laboratory Corporation of America Holdings (NYSE:LH) earned “Buy” rating by Craig Hallum on Wednesday, February 7. The rating was maintained by Canaccord Genuity on Wednesday, January 3 with “Buy”. As per Monday, December 11, the company rating was downgraded by Credit Suisse. Canaccord Genuity maintained Laboratory Corporation of America Holdings (NYSE:LH) on Wednesday, February 28 with “Buy” rating. As per Friday, November 24, the company rating was maintained by Jefferies. Credit Suisse maintained the shares of LH in report on Thursday, March 1 with “Outperform” rating. The rating was maintained by SunTrust on Thursday, January 11 with “Buy”. On Friday, December 1 the stock rating was maintained by Mizuho with “Hold”. The firm earned “Hold” rating on Tuesday, March 6 by Jefferies.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.